TSPAN32 and myeloid sarcoma: As LIMMA analysis revealed significant transcriptomic differences between tetramer- MS memory T cells and tetramer- HD memory T cells, with enrichment of several immune-related biological processes (Figure S1A,B), and HCL analysis clustered together tetramer- and tetramer+ memory T cells from MS patients (Figure S1C), the reduced TSPAN32 levels may be associated to a reduced activation threshold of memory T cells from MS patients, and could explain the underlying autoimmune process.